ReviewCurrent treatment options in cardiovascular medicine2026
Vascular Phenotyping with Photoacoustic and Ultrasound Imaging in Cardiovascular Disease: Recent Innovations.
Review in Current treatment options in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Purpose of Review: Photoacoustic and ultrasound imaging together resolve vascular structure, wall biomechanics, blood flow, oxygenation, and tissue composition without ionizing radiation or iodinated contrast. This review summarizes what each modality can now measure in patients and asks which of these measurements are close enough to clinical use to inform cardiovascular management decisions. Recent Findings: Recent advances have expanded photoacoustic imaging toward faster, higher-resolution functional vascular phenotyping, including clinically relevant biomarkers and co-registered ultrasound imaging. Ultrafast and super-resolution ultrasound now quantify vascular biomechanics, hemodynamics, and microvasculature, with ultrasound localization microscopy entering clinical studies. Wearable ultrasound has also been validated for blood-pressure monitoring across diverse care settings, alongside increasingly quantitative feature extraction. Summary: Ultrasound and photoacoustic imaging provide complementary vascular information: ultrasound offers depth, speed, and continuous access, while photoacoustic imaging adds compositional and oxygenation contrast. Despite limitations in quantitative accuracy, imaging depth, and system standardization, emerging patient studies now span super-resolution vascular mapping, functional biomarkers, and wearable monitoring. Their integration offers a potential route toward continuous, operator-independent vascular phenotyping for clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.